PyInvesting

Market research

SN.LSE Smith & Nephew plc

LSE GBP Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
9B
P/E ratio
19.89
Analyst target
1287.1947
Dividend yield
3.6%
Beta
0.69

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Smith & Nephew plc is currently in a long term uptrend where the price is trading 4.8% above its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.

Smith & Nephew plc's total revenue sank by 0.0% to $1B since the same quarter in the previous year.

Its net income has dropped by 0.0% to $146M since the same quarter in the previous year.

Finally, its free cash flow grew by 31.4% to $304M since the same quarter in the previous year.

Based on the above factors, Smith & Nephew plc gets an overall score of 3/5.